Atlas Trials

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

Clinical trial NCT05137067 · COMPLETED

Trial details

NCT number
NCT05137067
Sponsor
Optimal Health Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerLung CancerProstate Cancer
Start date
2021-01-20
Primary completion
2022-10-18
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.